Metformin Treatment Does Not Affect Testicular Size in Offspring Born to Mothers with Gestational Diabetes

Article View

The Review of Diabetic Studies,2016,13,1,59-65.
Published:May 2016
Type:Original Article
Author(s) affiliations:

Kristiina Tertti1, Jorma Toppari2, Helena E. Virtanen2, Sergey Sadov2, and Tapani Rönnemaa3

1Department of Obstetrics and Gynecology, University of Turku and Turku University Hospital, Turku, FINLAND.

2Departments of Physiology and Pediatrics, University of Turku, Turku, FINLAND.

3Department of Medicine, University of Turku and Turku University Hospital, Turku, FINLAND.


Objectives: Studies in rodents suggest that metformin treatment during pregnancy may have harmful effects on testicular development in offspring. Our aim was to determine whether metformin treatment of gestational diabetes mellitus (GDM) affects testicular size in male offspring. Methods: We compared the testicular size in prepubertal boys born to mothers who participated in a randomized controlled trial (RCT) comparing metformin with insulin in the treatment of GDM. Twenty-five (42.4% of invited) and 27 (52.9% of invited) boys whose mothers had been treated with metformin or insulin, respectively, participated in the study. Testicular size was measured by a ruler, an orchidometer, and by ultrasonography at the age of 33 to 85 months. Results: The mean age of the boys was 60 months at the time of examination, and did not differ between the metformin and insulin group (p = 0.88). There was no difference in testicular size between the boys in the two groups (p always ≥ 0.40), and there were no significant differences in height, weight, BMI, BMI z-score, or waist-to-hip ratio (WHR) between the boys in the groups. Conclusion: Prepubertal testicular size did not differ between offspring born to metformin-treated mothers and those born to insulin- treated mothers.